Boussard & Gavaudan Investment Management LLP Genfit S.A. Transaction History

Boussard & Gavaudan Investment Management LLP

  • $121 Million
  • Q1 2025

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 22, 2019
SELL
$14.92 - $19.94 $149,259 - $199,479
-10,004 Closed
0 $0
Q2 2019

Jul 24, 2019
BUY
$19.74 - $25.65 $197,478 - $256,602
10,004 New
10,004 $199,000

Others Institutions Holding GNFT

# of Institutions
9
Shares Held
209K
Call Options Held
0
Put Options Held
0
View Full List

About Genfit S.A.

GNFT Quotes by TradingView
  • Ticker GNFT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,815,500
  • Market Cap $192M
  • Description
  • Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...
More about GNFT
Track This Portfolio

Track Boussard & Gavaudan Investment Management LLP Portfolio

Follow Boussard & Gavaudan Investment Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boussard & Gavaudan Investment Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Boussard & Gavaudan Investment Management LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email